358 related articles for article (PubMed ID: 14722292)
1. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes.
Schaeffer E; Soros VB; Greene WC
J Virol; 2004 Feb; 78(3):1375-83. PubMed ID: 14722292
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
Schaeffer E; Geleziunas R; Greene WC
J Virol; 2001 Mar; 75(6):2993-3000. PubMed ID: 11222724
[TBL] [Abstract][Full Text] [Related]
3. Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells.
Muthumani K; Montaner LJ; Ayyavoo V; Weiner DB
DNA Cell Biol; 2000 Mar; 19(3):179-88. PubMed ID: 10749170
[TBL] [Abstract][Full Text] [Related]
4. Direct visualization of HIV-1 entry: mechanisms and role of cell surface receptors.
Stauber RH; Rulong S; Palm G; Tarasova NI
Biochem Biophys Res Commun; 1999 May; 258(3):695-702. PubMed ID: 10329448
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
6. Endocytic entry of HIV-1.
Fackler OT; Peterlin BM
Curr Biol; 2000 Aug; 10(16):1005-8. PubMed ID: 10985390
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis.
Herold N; Anders-Ößwein M; Glass B; Eckhardt M; Müller B; Kräusslich HG
J Virol; 2014 Dec; 88(24):13956-70. PubMed ID: 25253335
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.
Holm GH; Zhang C; Gorry PR; Peden K; Schols D; De Clercq E; Gabuzda D
J Virol; 2004 May; 78(9):4541-51. PubMed ID: 15078935
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.
Cavrois M; Neidleman J; Yonemoto W; Fenard D; Greene WC
Virology; 2004 Oct; 328(1):36-44. PubMed ID: 15380356
[TBL] [Abstract][Full Text] [Related]
10. Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material.
Tardif MR; Tremblay MJ
J Virol; 2003 Nov; 77(22):12299-309. PubMed ID: 14581566
[TBL] [Abstract][Full Text] [Related]
11. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
Yonezawa A; Cavrois M; Greene WC
J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Fusion with CD4+ T cells Is Promoted by Proteins Involved in Endocytosis and Intracellular Membrane Trafficking.
Marin M; Kushnareva Y; Mason CS; Chanda SK; Melikyan GB
Viruses; 2019 Jan; 11(2):. PubMed ID: 30691001
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.
de la Vega M; Marin M; Kondo N; Miyauchi K; Kim Y; Epand RF; Epand RM; Melikyan GB
Retrovirology; 2011 Dec; 8():99. PubMed ID: 22145853
[TBL] [Abstract][Full Text] [Related]
14. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
LaBonte JA; Madani N; Sodroski J
J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
[TBL] [Abstract][Full Text] [Related]
15. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.
Kobinger GP; Borsetti A; Nie Z; Mercier J; Daniel N; Göttlinger HG; Cohen A
J Virol; 1998 Jul; 72(7):5441-8. PubMed ID: 9620999
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.
Neil SJ; Eastman SW; Jouvenet N; Bieniasz PD
PLoS Pathog; 2006 May; 2(5):e39. PubMed ID: 16699598
[TBL] [Abstract][Full Text] [Related]
17. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.
Lundquist CA; Zhou J; Aiken C
J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722
[TBL] [Abstract][Full Text] [Related]
18. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.
Venzke S; Michel N; Allespach I; Fackler OT; Keppler OT
J Virol; 2006 Nov; 80(22):11141-52. PubMed ID: 16928758
[TBL] [Abstract][Full Text] [Related]
19. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.
Kozak SL; Heard JM; Kabat D
J Virol; 2002 Feb; 76(4):1802-15. PubMed ID: 11799176
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.
Fredericksen BL; Wei BL; Yao J; Luo T; Garcia JV
J Virol; 2002 Nov; 76(22):11440-6. PubMed ID: 12388705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
